Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research
2 other identifiers
interventional
60
1 country
1
Brief Summary
This study evaluates a visual Informed Consent Form (ICF) compared to a standard, text-only ICF as an approach to achieving meaningful consent into a clinical trial. The visual ICF uses cartoon characters, graphics and easy-to-understand text to cover the full content of a standard, text-only ICF. In this study, women who are considering enrollment into a clinical trial of a nutrition intervention for their infants will be randomized to either the visual ICF or to the text-only ICF. Qualitative and quantitative data will be collected immediately after the consent process and 8 weeks later. In addition, women not eligible for enrollment into the infant nutrition trial will be asked questions about their opinions regarding the visual ICF. The overall goal of the sub-study is to inform efforts to improve meaningful consent into clinical trials by evaluating whether the visual ICF improves understanding of the trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2024
CompletedFirst Submitted
Initial submission to the registry
August 8, 2025
CompletedFirst Posted
Study publicly available on registry
August 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
August 14, 2025
August 1, 2025
1.7 years
August 8, 2025
August 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Summed score from the validated Quality of Informed Consent (QUIC) instrument.
The QUIC measures knowledge recall. The summed score of 10 knowledge items comprising key concepts of informed consent will be calculated. The scores range between 0 and 22 with higher scores indicating higher knowledge.
Immediately after the consent process (Day 0) and 8 weeks later
Secondary Outcomes (2)
Self-rated Understanding
Immediately after consent process (Day 0)
Decision Regret Scale
8 weeks after consent process
Study Arms (2)
Visual Informed Consent Form (ICF)
EXPERIMENTALText-only Informed Consent Form
ACTIVE COMPARATORInterventions
This visual ICF fully represents all the content of the standard, text-only ICF using cartoon characters, graphics and easy text.
Eligibility Criteria
You may qualify if:
- Women ages 18-45 years of age
- Pregnant women or women that have recently given birth within the past 2-6 weeks
You may not qualify if:
- Unwilling to provide consent
- Severe maternal or infant illness (e.g. tuberculosis, major psychiatric or neurological conditions)
- Inability to communicate in one of the three languages (English, isiXhosa, or Afrikaans)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stellenbosch University Wooster Rural Campus
Worcester, Western Cape, 6850, South Africa
Study Officials
- PRINCIPAL INVESTIGATOR
Louise Kuhn, PhD
Columbia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Epidemiology
Study Record Dates
First Submitted
August 8, 2025
First Posted
August 14, 2025
Study Start
September 2, 2024
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
August 14, 2025
Record last verified: 2025-08